AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24090384
Drug: Magnesium orotate
RxNorm normalized name: Magnesium orotate
DrugBank: Magnesium orotate (DB13786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium orotate and other antihypertensive, metabolic drugs, sedative and uroseptic phytotherapy, and nondrug measures
Trial: 17144787
Drug: Complementary medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary medicine (including acupuncture, aromatherapy, massage, homeopathy, meditation, reflexology, herbal medicine, yoga, dietary supplements, relaxation techniques)
Trial: 15686716
Drug: Steroid weaning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid weaning
Trial: 8783703
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg b.i.d. for 5 days)
Trial: 6508263
Drug: Comparative agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparative agents (piperacillin or moxalactam)
Trial: 28724815
Drug: Intracameral mydriatic
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intracameral mydriatic solution
Trial: 14709298
Drug: Topical mydriatics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical mydriatics
Trial: 22999400
Drug: Intrathecal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal administration of 10mg of 0.5% hyperbaric bupivacaine combined with 80 mcg of morphine and 2.5 mcg of sufentanil
Trial: 22999400
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving 10mg of 0.5% hyperbaric bupivacaine combined with 80 mcg of morphine
Trial: 17488312
Drug: Ketamine 1
RxNorm normalized name: ketamine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1 mg/kg (Group K1)
Trial: 17488312
Drug: Ketamine 2
RxNorm normalized name: esketamine 28 mg nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 2 mg/kg (Group K2)
Trial: 17488312
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 mg/kg (Group P)
Trial: 15034949
Drug: Benznidazole (BZ)
RxNorm normalized name: benznidazole
DrugBank: Benznidazole (DB11989)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benznidazole (BZ) with Thioctic Acid (TA) at daily doses of 50 to 100 mg for 30 days
Trial: 9630294
Drug: Full standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full standardized dose of laser (40 x 1500 mW for 1500 ms)
Trial: 9630294
Drug: Half standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half standardized dose of laser (40 x 750 mW for 1500 ms)
Trial: 9630294
Drug: Full treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full treatment subgroup with neovascular glaucoma
Trial: 7983235
Drug: Nifedipine 50
RxNorm normalized name: nifedipine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 50 mg once a day
Trial: 7983235
Drug: Nifedipine retard
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine retard 20 mg twice a day
Trial: 2512486
Drug: Isocaloric protein‐restricted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric protein‐restricted diet (0.4 g of protein per kilogram of body weight per day)
Trial: 28104250
Drug: Daclizumab 150mg
RxNorm normalized name: DACLIZUMAB 150MG/ML SYR
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab 150mg subcutaneous every 4 weeks
Trial: 28104250
Drug: Interferon beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a 30mcg intramuscular once weekly
Trial: 21777736
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 28 days prior to tick infestation.
Trial: 21777736
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 21 days prior to tick infestation.
Trial: 21777736
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 14 days prior to tick infestation.
Trial: 19433838
Drug: Multimodal cancer
RxNorm normalized name: Cancer/testis antigen 1
DrugBank: Cancer/testis antigen 1 (DB19291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal cancer screening (including CA-125 tests, transvaginal sonograms, chest radiographs, flexible sigmoidoscopies, digital rectal examinations, and serum PSA tests)
Trial: 11045914
Drug: Low-dose PGE1
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose PGE1 (2.5 - 5.0 microg)
Trial: 11045914
Drug: Standard sex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard sex therapy for twelve weeks
Trial: 8443935
Drug: Tretinoin emollient
RxNorm normalized name: Tretinoin Emollient Topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin emollient cream 0.01%
Trial: 1552056
Drug: Tretinoin emollient
RxNorm normalized name: Tretinoin Emollient Topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin emollient cream 0.001%
Trial: 3886304
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg brompheniramine maleate
Trial: 3886304
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg clemastine fumarate
Trial: 24354588
Drug: 13-valent conjugated
RxNorm normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13-valent conjugated pneumococcal vaccine
Trial: 10090927
Drug: Busulfan 16
RxNorm normalized name: Busulfan
DrugBank: Busulfan (DB01008)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Busulfan 16 mg/kg
Trial: 7884425
Drug: Docetaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (100 mg/m2 intravenously over 1 hour every 3 weeks)
Trial: 2206058
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution injections
Trial: 2206058
Drug: No injections
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injections
Trial: 6108392
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (2 doses of 40 micrograms)
Trial: 6108392
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (3 doses of 40 micrograms)
Trial: 6108392
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of Hepatitis B vaccine
Trial: 28747328
Drug: Daily meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily meal replacements of 1-2 meals for 3 years
Trial: 24877791
Drug: Talking about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talking about stories of difficulty (treatment)
Trial: 24877791
Drug: Daily events
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily events (control)
Trial: 23906400
Drug: Low-dose L-amlodipine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose L-amlodipine besylate (2.5 mg/d)
Trial: 23906400
Drug: High-dose L-amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose L-amlodipine besylate (5.0 mg/d)
Trial: 23906400
Drug: Amlodipine maleate
RxNorm normalized name: Amlodipine Maleate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine maleate (5.0 mg/d)
Trial: 19595142
Drug: T0901317, 9‐cis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T0901317, 9‐cis retinoic acid, chenodeoxycholic acid (CDCA) - agonists of LXR, RXR, FXR
Trial: 16563905
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg twice daily
Trial: 11267622
Drug: Nicotine (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (21 mg/24 h)
Trial: 11267622
Drug: Nicotine (42
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (42 mg/24 h)
Trial: 3174738
Drug: Mecamylamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mecamylamine (10 mg)
Trial: 7860158
Drug: All strains
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All strains of measles vaccine
Trial: 2680162
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day methylprednisolone for 3 days
Trial: 2680162
Drug: 1,000 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg/day methylprednisolone for 3 days
Trial: 788430
Drug: Control insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control insulin tolerance test
Trial: 23234491
Drug: Ditto™ intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ditto™ intervention group (receiving Ditto™, procedural preparation and Ditto™ distraction)
Trial: 10211919
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg/day, flexible titration up to 200 mg/day)
Trial: 2223140
Drug: Simple mastectomy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple mastectomy with postoperative x-ray treatment
Trial: 2198932
Drug: Acetazolamide tablets
RxNorm normalized name: Acetazolamide Tablets
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide tablets
Trial: 23862400
Drug: Intranasal sodium
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal sodium hyaluronate
Trial: 21209236
Drug: Tadalafil 10
RxNorm normalized name: tadalafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 10 mg (TAD) alone
Trial: 21209236
Drug: Tadalafil 10
RxNorm normalized name: tadalafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 10 mg (TAD) with tipranavir/ritonavir (TPV/r) 500/200 mg
Trial: 21209236
Drug: Tadalafil 10
RxNorm normalized name: tadalafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 10 mg (TAD) with steady-state TPV/r
Trial: 15190136
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of ondansetron
Trial: 15098526
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg of dolasetron
Trial: 9519171
Drug: MXL capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MXL capsules (once-daily morphine preparation)
Trial: 9519171
Drug: MST Continus
RxNorm normalized name: MST Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MST Continus tablets (twice-daily morphine preparation)
Trial: 27862179
Drug: (S)-ketamine 10
RxNorm normalized name: (S)-(-)-ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-ketamine 10 mg
Trial: 27862179
Drug: phenytoin 300
RxNorm normalized name: phenytoin 300 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: phenytoin 300 mg
Trial: 27862179
Drug: pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pregabalin 300 mg
Trial: 27862179
Drug: fentanyl 3
RxNorm normalized name: FENTANYL 37.5MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fentanyl 3 μg kg-1
Trial: 27862179
Drug: ibuprofen 600
RxNorm normalized name: ibuprofen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 600 mg
Trial: 25216597
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin therapy (EPT+) in normotensive women
Trial: 25216597
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/day) in hypertensive women
Trial: 25216597
Drug: Hydrochlorothiazide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (25 mg/day) in hypertensive women
Trial: 25216597
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin therapy (EPT+) with Hydrochlorothiazide in hypertensive women
Trial: 25216597
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin therapy (EPT+) with Perindopril in hypertensive women
Trial: 24334578
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches over semipermeable membrane dressings (SMD)
Trial: 24334578
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches without semipermeable membrane dressings (SMD)
Trial: 16249215
Drug: Paclitaxel 225
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 225 mg/m2 every 3 weeks x 4 cycles with concurrent carboplatin AUC 6 every 3 weeks x 4 cycles
Trial: 16249215
Drug: Paclitaxel 75
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 75 mg/m2/week x 12 with concurrent carboplatin AUC 6 every 3 weeks x 4 cycles
Trial: 11101062
Drug: scIL-2 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: scIL-2 therapy plus antiretroviral therapy
Trial: 11101062
Drug: antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antiretroviral therapy alone (control group)
Trial: 7813412
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) monotherapy
Trial: 30345905
Drug: Palbociclib plus
RxNorm normalized name: Palbociclib
DrugBank: Palbociclib (DB09073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Palbociclib plus fulvestrant (among patients with sensitivity to previous endocrine therapy)
Trial: 30345905
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus fulvestrant (among patients with sensitivity to previous endocrine therapy)
Trial: 21745388
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (2 times per week for 12 sessions over 6 weeks)
Trial: 21745388
Drug: Waitlist control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlist control (no acupuncture treatment for the first 6 weeks)
Trial: 8233298
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with carboplatin (400 mg/m2 day 1) and 5-fluorouracil (1 g/m2 days 1-5) followed by locoregional treatment (LRT)
Trial: 8233298
Drug: Locoregional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locoregional treatment (LRT) alone
Trial: 2891370
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg famotidine orally alone
Trial: 2891370
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg famotidine orally with antacid
Trial: 2891370
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg famotidine orally with a standard breakfast
Trial: 28631456
Drug: Adenosine group
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine group (20 mL of bupivacaine hydrochloride 0.375% + 12 mg adenosine in 2 mL of saline 0.9%)
Trial: 28631456
Drug: Magnesium group
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium group (20 mL of bupivacaine hydrochloride 0.375% + 500 mg magnesium sulphate in 2 mL saline 0.9%)
Trial: 28631456
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20 mL of bupivacaine hydrochloride 0.375% + 2 mL saline 0.9%)
Trial: 27236075
Drug: No-treatment condition
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment condition (n = 13)
Trial: 26817717
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg FA/d
Trial: 20620713
Drug: Carotid Augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid Augmentation Index (cAI(x))
Trial: 16614274
Drug: Nicorandil added
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil added to existing antianginal treatment
Trial: 10649211
Drug: Investigational drug
RxNorm normalized name: INVESTIGATIONAL DRUGS FOR DEMENTIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational drug (placebo-controlled)
Trial: 8402740
Drug: diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diltiazem 60 mg tid
Trial: 8402740
Drug: diltiazem SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diltiazem SR 120 mg bid
Trial: 3079940
Drug: PY 108-068
RxNorm normalized name: KETOCONAZ 2% GEL/ZINC PY 1% SHAMPOO KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PY 108-068 (75 mg/day)
Trial: 3079940
Drug: PY 108-068
RxNorm normalized name: KETOCONAZ 2% GEL/ZINC PY 1% SHAMPOO KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PY 108-068 (150 mg/day)
Trial: 29111391
Drug: Antimicrobial photodynamic
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial photodynamic therapy (aPDT) with scaling and root planing (SRP)
Trial: 29111391
Drug: Antimicrobial photodynamic
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial photodynamic therapy (aPDT) with SRP
Trial: 18180637
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% lidocaine
Trial: 18180637
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% amitriptyline
Trial: 12526955
Drug: L-NMMA (12.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (12.5, 25, and 50 microg/kg/min for Low; 25, 50, and 100 microg/kg/min for High)
Trial: 12526955
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline infusions only)
Trial: 20560730
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg once daily
Trial: 8730416
Drug: Calcium dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dialysate (CaD) of 1.75 mmol/l
Trial: 8730416
Drug: Calcium dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dialysate (CaD) of 1.25 mmol/l
Trial: 1407617
Drug: Antibiotic pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic pretreatment of heart valve prostheses
Trial: 3930246
Drug: Aspirin 0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 0.45 mg kg‐1 day‐1
Trial: 24612027
Drug: Superficial dermabrasion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superficial dermabrasion (16 weekly sessions)
Trial: 24612027
Drug: Topical tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tretinoin cream (0.05% daily)
Trial: 19854610
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate (DAB) 110 mg
Trial: 19854610
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate (DAB) 150 mg
Trial: 19854610
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate (DAB) 220 mg
Trial: 17913961
Drug: TNF-alpha -308
RxNorm normalized name: alpha-Tocopherolquinone
DrugBank: Tocopherylquinone (DB14094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha -308 G/A allele frequencies in women with pregnancy complications (cases)
Trial: 17913961
Drug: TNF-alpha -308
RxNorm normalized name: alpha-Tocopherolquinone
DrugBank: Tocopherylquinone (DB14094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha -308 G/A allele frequencies in women without pregnancy complications (controls)
Trial: 17913961
Drug: TNF-alpha -308
RxNorm normalized name: alpha-Tocopherolquinone
DrugBank: Tocopherylquinone (DB14094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha -308 G/A genotype distributions in women with pregnancy complications (cases)